1. Home
  2. EDAP vs ARCT Comparison

EDAP vs ARCT Comparison

Compare EDAP & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EDAP TMS S.A.

EDAP

EDAP TMS S.A.

HOLD

Current Price

$3.41

Market Cap

163.4M

Sector

Health Care

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$8.46

Market Cap

189.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDAP
ARCT
Founded
1979
2013
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
163.4M
189.9M
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
EDAP
ARCT
Price
$3.41
$8.46
Analyst Decision
Hold
Buy
Analyst Count
1
11
Target Price
$2.00
$27.70
AVG Volume (30 Days)
39.8K
508.0K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
$70,527,000.00
$82,031,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.63
N/A
52 Week Low
$1.21
$5.85
52 Week High
$5.05
$24.14

Technical Indicators

Market Signals
Indicator
EDAP
ARCT
Relative Strength Index (RSI) 36.24 67.30
Support Level $1.98 $6.90
Resistance Level $3.44 $8.65
Average True Range (ATR) 0.34 0.47
MACD -0.03 0.21
Stochastic Oscillator 29.35 78.17

Price Performance

Historical Comparison
EDAP
ARCT

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: